Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Other Working Capital Changes: 2010-2024

Historic Other Working Capital Changes for OptimizeRx (OPRX) over the last 15 years, with FY2024 value amounting to $1.4 million.

  • OptimizeRx's Other Working Capital Changes fell 9844.36% to -$510000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $374000.0, marking a year-over-year decrease of 650.0%. This contributed to the annual value of $1.4 million for FY2024, which is 11883.04% up from last year.
  • Per OptimizeRx's latest filing, its Other Working Capital Changes stood at $1.4 million for FY2024, which was up 11883.04% from -$7.7 million recorded in FY2023.
  • In the past 5 years, OptimizeRx's Other Working Capital Changes ranged from a high of $3.5 million in FY2020 and a low of -$7.7 million during FY2023
  • Its 5-year average for Other Working Capital Changes is -$841041.4, with a median of $1.2 million in 2021.
  • As far as peak fluctuations go, OptimizeRx's Other Working Capital Changes soared by 92306.9% in 2020, and later tumbled by 32579.66% in 2022.
  • OptimizeRx's Other Working Capital Changes (Annual) stood at $3.5 million in 2020, then crashed by 66.62% to $1.2 million in 2021, then crashed by 325.8% to -$2.7 million in 2022, then tumbled by 190.27% to -$7.7 million in 2023, then skyrocketed by 118.83% to $1.4 million in 2024.
  • Its Other Working Capital Changes was $1.4 million in FY2024, compared to -$7.7 million in FY2023 and -$2.7 million in FY2022.